Secondary Logo

Institutional members access full text with Ovid®

Arterial Phase 18F-Fluorocholine PET/CT in Hepatocellular Carcinoma

Legendre, Alexandre, MD*; Collet, Guillaume, MD; Lahousse, Hélène, MD*; Aziz, Anne-Laure, MD*; Petyt, Grégory, MD*

doi: 10.1097/RLU.0000000000002397
Interesting Images
Buy
SDC

A 57-year-old man was referred to our institution for 18F-fluorocholine PET/CT to characterize a pulmonary nodule in a context of hepatocellular carcinoma. 18F-FDG PET/CT did not show any uptake of the pulmonary nodule. 18F-fluorocholine PET/CT showed high uptake of the pulmonary nodule, confirming its metastatic origin. Furthermore, liver early dynamic acquisitions allowed better visualization of the hepatocellular carcinoma during the “arterial phase” than at equilibrium.

From the *CHU Lille, Department of Nuclear Medicine, Salengro Hospital, Lille; and

CH Valenciennes, Department of Nuclear Medicine, Valenciennes, France.

Received for publication July 9, 2018; revision accepted October 13, 2018.

Conflicts of interest and sources of funding: none declared.

Correspondence to: Alexandre Legendre, MD, Service de Médecine Nucléaire, Centre Hospitalier Régional Universitaire de Lille, 2, Avenue Oscar Lambret, 59037 Lille Cedex, France. E-mail: legendre.alexandre@hotmail.fr.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.